Announcements Trials
Browse Landscape

Phase

Phase 1/2 4Phase 1 4Phase EARLY_PHASE1 1Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Dermatologic 1Breast 1

Conditions

Melanoma 5Neoplasms 3Glioma 3Glioblastoma 3Squamous Cell Carcinoma of Head and Neck 2Gliosarcoma 2Central Nervous System Neoplasms 2Brain Neoplasms 2Uveal Melanoma 1Triple Negative Breast Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Oligodendroglioma 1Neoplasms, Plasma Cell 1Head and Neck Neoplasms 1Ependymoma 1Breast Neoplasms 1Astrocytoma 1

Interventions

Trastuzumab 303Paclitaxel 256Cyclophosphamide 251Docetaxel 238Capecitabine 175Letrozole 163Carboplatin 163Doxorubicin 145Fulvestrant 144Bevacizumab 121Anastrozole 106Tamoxifen 102exemestane 94Vinorelbine 91Epirubicin 90pertuzumab 88Gemcitabine 84Lapatinib 80Albumin-Bound Paclitaxel 74Radiotherapy 71pembrolizumab 70palbociclib 64130-nm albumin-bound paclitaxel 58eribulin 56Cisplatin 55Everolimus 49pyrotinib 44Taxes 44Goserelin 43Neoadjuvant Therapy 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Breast Neoplasms × poly ICLC × Clear all
NCT01984892 2018-01-23

Hiltonol

Icahn School of Medicine at Mount Sinai

Phase 2 Terminated
8 enrolled 4 charts
BreastDermatologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡